Canaan Partners IX LLC, Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 50,164 shares at $10.60 ($532K) on 2016-05-27, disclosed to the SEC on 2016-06-01.
Open-market sale of $532k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.60 | 25,082 | $266K | 50.0% |
| 2 | $10.60 | 25,082 | $266K | 50.0% |
| Total | $10.60 avg | 50,164 | $532K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-10 | $303K | — | Filing → |